Search
Results: 683
The RA-MAP Consortium
Andrew P Cope, Michael R Barnes, Alexandra Belson, Michael Binks, Sarah Brockbank, Francisco Bonachela-Capdevila, Claudio Carini, Benjamin A Fisher, Carl S Goodyear, Paul Emery, Michael R Ehrenstein, Neil Gozzard, Ray Harris, Sally Hollis, Sarah Keidel, Marc Levesque, Catharina Lindholm, Michael F McDermott, Iain B McInnes, Christopher M Mela, Gerry Parker, Simon Read, Ayako Wakatsuki Pedersen, Frederique Ponchel, Duncan Porter, Ravi Rao, Anthony Rowe, Peter Schulz-Knappe, Matthew A Sleeman, Deborah Symmons, Peter C Taylor, Brian Tom, Wayne Tsuji, Denny Verbeeck, John D Isaacs, RA-MAP Consortium
Jun 19, 2018
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study)
Mariam Al-Laith, Marianna Jasenecova, Sonya Abraham, Aisla Bosworth, Ian N Bruce, Christopher D Buckley, Coziana Ciurtin, Maria-Antonietta D'Agostino, Paul Emery, Hill Gaston, John D Isaacs, Andrew Filer, Benjamin A Fisher, Thomas WJ Huizinga, Pauline Ho, Clare Jacklin, Heidi Lempp, Iain B McInnes, Arthur G Pratt, Andrew Östor, Karim Raza, Peter C Taylor, Dirkjan van Schaardenburg, Dharshene Shivapatham, Alison J Wright, Joana C Vasconcelos, Joanna Kelly, Caroline Murphy, A Toby Prevost, Andrew P Cope
Jul 14, 2020
TRIAL DESIGN: We present a study protocol for a multi-centre, randomised, double-blind, parallel-group, placebo-controlled trial that seeks to test the feasibility, acceptability and effectiveness of a 52-week period of...
Abatacept Antibodies to citrullinated protein antigens At risk Autoantibodies Double-blind intervention Placebo-controlled Pre-clinical phase Randomised rheumatoid arthritis Abatacept Antirheumatic Agents Arthritis Rheumatoid Autoantibodies Biomarkers Double-Blind Method Drug Administration Schedule Feasibility Studies Female Humans Male Multicenter Studies as Topic Netherlands Pregnancy Randomized Controlled Trials as Topic Time Factors Treatment Outcome United Kingdom
Active faulting within a megacity
M Talebian, AC Copley, M Fattahi, M Ghorashi, JA Jackson, H Nazari, RA Sloan, RT Walker
Dec 08, 2016
The Seventeenth Data Release of the Sloan Digital Sky Surveys
Abstract
This paper documents the seventeenth data release (DR17) from the Sloan Digital Sky Surveys; the fifth and final release from the fourth phase (SDSS-IV). DR17 contains the...
Abdurro'Uf, K Accetta, C Aerts, V Silva Aguirre, R Ahumada, N Ajgaonkar, N Filiz Ak, S Alam, C Allende Prieto, A Almeida, F Anders, SF Anderson, BH Andrews, B Anguiano, E Aquino-Ortíz, A Aragón-Salamanca, M Argudo-Fernández, M Ata, M Aubert, V Avila-Reese, C Badenes, RH Barbá, K Barger, JK Barrera-Ballesteros, RL Beaton, TC Beers, F Belfiore, CF Bender, M Bernardi, MA Bershady, F Beutler, CM Bidin, JC Bird, D Bizyaev, GA Blanc, MR Blanton, NF Boardman, AS Bolton, M Boquien, J Borissova, J Bovy, WN Brandt, J Brown, JR Brownstein, M Brusa, J Buchner, K Bundy, JN Burchett, M Bureau, A Burgasser, TK Cabang, S Campbell, M Cappellari, JK Carlberg, FC Wanderley, R Carrera, J Cash, YP Chen, WH Chen, B Cherinka, C Chiappini, PD Choi, SD Chojnowski, H Chung, N Clerc, RE Cohen, JM Comerford, J Comparat, L Da Costa, K Covey, JD Crane, I Cruz-Gonzalez, C Culhane, K Cunha, YS Dai, G Damke, J Darling, JW Davidson, R Davies, K Dawson, N De Lee, AM Diamond-Stanic, M Cano-Díaz, HD Sánchez, J Donor, C Duckworth, T Dwelly, DJ Eisenstein, YP Elsworth, E Emsellem, M Eracleous, S Escoffier, X Fan, E Farr, S Feng, JG Fernández-Trincado, D Feuillet, A Filipp, SP Fillingham, PM Frinchaboy
Mar 17, 2022
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
Sofia Ramiro, Robert Bm Landewé, Désirée van der Heijde, Alexandre Sepriano, Oliver FitzGerald, Mikkel Ostergaard, Joanne Homik, Ori Elkayam, J Carter Thorne, Margaret Larche, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G Cantagrel, Cornelia F Allaart, Cheryl Barnabe, Clifton O Bingham, Paul P Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P Maksymowych
Feb 25, 2020
OBJECTIVES: To investigate whether following a treat-to-target (T2T)-strategy in daily clinical practice leads to more patients with rheumatoid arthritis (RA) meeting the remission target. METHODS: RA patients from 10 countries...
Remission rheumatoid arthritis treat-to-target Adult Aged Antirheumatic Agents Arthritis Rheumatoid Blood Sedimentation C-Reactive Protein Clinical Decision-Making Cohort Studies Female Humans Longitudinal Studies Male Middle Aged Patient Care Planning Remission Induction Rheumatoid Factor Tumor Necrosis Factor Inhibitors
Increased Frequency of CD4+ Follicular Helper T and CD8+ Follicular T Cells in Human Lymph Node Biopsies during the Earliest Stages of Rheumatoid Arthritis.
Dornatien Chuo Anang, Tamara H Ramwadhdoebe, Janine S Hähnlein, Bo van Kuijk, Noortje Smits, Krijn P van Lienden, Mario Maas, Daniëlle M Gerlag, Paul P Tak, Niek de Vries, Lisa GM van Baarsen
May 13, 2022
Follicular T helper cells (Tfh cells) provide key B-cell help and are essential in germinal center formation and (auto) antibody generation. To gain more insight into their role during the earliest phase of rheumatoid arthritis...
Estimating the diagnostic accuracy of rheumatoid factor in UK primary care
Anne Miller, Alison L. Nightingale, Cormac J. Sammon, Kamal R. Mahtani, Tim A. Holt, Neil J. McHugh, Raashid A. Luqmani
Oct 01, 2015
OBJECTIVE: To investigate the diagnostic accuracy of RF as a test for RA in primary care and its impact on referral times using the Clinical Practice Research Datalink.
METHODS: We identified all patients with a first...
Human Lymph Node Stromal Cells Have the Machinery to Regulate Peripheral Tolerance during Health and Rheumatoid Arthritis.
Janine S Hähnlein, Reza Nadafi, Tineke A de Jong, Johanna F Semmelink, Ester BM Remmerswaal, Mary Safy, Krijn P van Lienden, Mario Maas, Danielle M Gerlag, Paul P Tak, Reina E Mebius, Heidi Wähämaa, Anca I Catrina, Lisa G M van Baarsen
Aug 10, 2020
BACKGROUND: In rheumatoid arthritis (RA) the cause for loss of tolerance and anti-citrullinated protein antibody (ACPA) production remains unidentified. Mouse studies showed that lymph node stromal cells (LNSCs) maintain...
D?vad?ra
Joanna Henry
Jan 01, 0001
Artwork
Magazine Literary Magazine Arts Magazine art poetry prose Creative Nonfiction Photography Creative Writing Art and Design Photography
Published by: Winthrop University
'Cinderella's' fairytale ending curbed
Brian Sloan
Aug 15, 2016
This is the author accepted manuscript. The final version is available from Jordan Publishing.
Testamentary Freedom
This is a metadata record for a chapter that cannot be shared due to publisher copyright.
Predictors of heart rate recovery following exercise in patients with rheumatoid arthritis
Background Cardiovascular disease (CVD) is a major cause of death in rheumatoid arthritis patients (RA). The underlying mechanisms for the CVD increase risk in RA are not fully understood. However, poor parasympathetic function...
Fibrinogen marker C reactive protein triacylglycerol Lipid Heart Rate Exercise Patient human rheumatoid arthritis Rheumatology rheumatic disease Risk factor risk parasympathetic tone Quality of life parasympathetic function leukocyte Exercise Tolerance FITNESS breathing longitudinal study linear regression analysis treadmill Framingham risk score insulin sensitivity Oxygen Consumption Exercise Test cardiovascular disease POPULATION erythrocyte sedimentation rate Mortality Gender blood sampling Female gas analysis Cause of Death Quantitative Insulin Sensitivity Check Index electrocardiogram /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being name=SDG 3 - Good Health and Well-being
Physical ability of people with rheumatoid arthritis and age-sex matched controls to use four commonly prescribed inhaler devices
Background Respiratory disease is a common co-morbidity with rheumatoid arthritis (RA). RA commonly affects the hands, but there is little research investigating whether these patients are physically able to operate inhalers....
|
|< |
< |
1 |